SN BioScience Propels SNB-101 to Phase 2 with IND Clearance from FDA
Press Releases
SN BioScience Inc  
January 10, 2025

SN BioScience Propels SNB-101 to Phase 2 with IND Clearance from FDA

SEOUL, South Korea, Jan. 10, 2025 /PRNewswire/ -- SN BioScience today announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug

avatar profile Olean Times Herald

Olean Times Herald


Local & Social